Peptide Knowledge Center

What are the peptide drugs for treating diabetes on the global market?

Peptide refers to a compound with less than 100 amino acids linked twice through a peptide bond, and its relative molecular mass is less than 10,000. Polypeptide drugs are used in the treatment of tumors, diabetes, cardiovascular diseases, osteoporosis, gastrointestinal diseases, and central nervous system. , System diseases, immune diseases, antiviral, antibacterial, etc. have significant effects. There are more than 80 GMP peptide drugs approved for marketing globally, including 17 anti-tumor drugs, 7 diabetes treatment drugs, 16 infection and immunotherapy drugs, and 9 vascular and urinary system drugs. Here are the peptides for the treatment of diabetes:

 

Peptide drugTrade name 
IndicationsRoute of administrationFDA listing time

Exenatide

Byetta/Bydureon

Stage 2 diabetes

subcutaneous injection

2014

Albiglutide

Tanzeum 

Stage 2 diabetes

subcutaneous injection

2014

Dulaglucotide

Trulicity

Stage 2 diabetes

subcutaneous injection

2014

Liraglutide

Victoza 

Stage 2 diabetes and obesity

subcutaneous injection

2014

Lixilai

Lyxumia


subcutaneous injection

/

Pramlintide

Symlin

Phase 1,2 of diabetes

subcutaneous injection

2005

Glucagon

Glucagon

hypoglycemia

subcutaneous and intramuscular injection

1998